| UniProt ID | LAT3_HUMAN | |
|---|---|---|
| UniProt AC | O75387 | |
| Protein Name | Large neutral amino acids transporter small subunit 3 | |
| Gene Name | SLC43A1 {ECO:0000312|EMBL:AAH01639.1} | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 559 | |
| Subcellular Localization |
Membrane Multi-pass membrane protein . |
|
| Protein Description | Sodium-independent, high affinity transport of large neutral amino acids. Has narrower substrate selectivity compared to SLC7A5 and SLC7A8 and mainly transports branched-chain amino acids and phenylalanine. Plays a role in the development of human prostate cancer, from prostatic intraepithelial neoplasia to invasive prostate cancer.. | |
| Protein Sequence | MAPTLQQAYRRRWWMACTAVLENLFFSAVLLGWGSLLIILKNEGFYSSTCPAESSTNTTQDEQRRWPGCDQQDEMLNLGFTIGSFVLSATTLPLGILMDRFGPRPVRLVGSACFTASCTLMALASRDVEALSPLIFLALSLNGFGGICLTFTSLTLPNMFGNLRSTLMALMIGSYASSAITFPGIKLIYDAGVAFVVIMFTWSGLACLIFLNCTLNWPIEAFPAPEEVNYTKKIKLSGLALDHKVTGDLFYTHVTTMGQRLSQKAPSLEDGSDAFMSPQDVRGTSENLPERSVPLRKSLCSPTFLWSLLTMGMTQLRIIFYMAAVNKMLEYLVTGGQEHETNEQQQKVAETVGFYSSVFGAMQLLCLLTCPLIGYIMDWRIKDCVDAPTQGTVLGDARDGVATKSIRPRYCKIQKLTNAISAFTLTNLLLVGFGITCLINNLHLQFVTFVLHTIVRGFFHSACGSLYAAVFPSNHFGTLTGLQSLISAVFALLQQPLFMAMVGPLKGEPFWVNLGLLLFSLLGFLLPSYLFYYRARLQQEYAANGMGPLKVLSGSEVTA | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 4 | Phosphorylation | ----MAPTLQQAYRR ----CCCHHHHHHHH | 27.88 | 25072903 | |
| 9 | Phosphorylation | APTLQQAYRRRWWMA CCHHHHHHHHHHHHH | 10.58 | 25072903 | |
| 46 | Phosphorylation | ILKNEGFYSSTCPAE EEECCCCCCCCCCCC | 16.75 | - | |
| 57 | N-linked_Glycosylation | CPAESSTNTTQDEQR CCCCCCCCCCHHHHH | 42.97 | UniProtKB CARBOHYD | |
| 165 | Phosphorylation | NMFGNLRSTLMALMI CCCCCHHHHHHHHHH | 29.11 | 26552605 | |
| 166 | Phosphorylation | MFGNLRSTLMALMIG CCCCHHHHHHHHHHH | 17.70 | 26552605 | |
| 174 | Phosphorylation | LMALMIGSYASSAIT HHHHHHHHHHCCCCC | 13.45 | 26552605 | |
| 175 | Phosphorylation | MALMIGSYASSAITF HHHHHHHHHCCCCCC | 12.80 | 26552605 | |
| 177 | Phosphorylation | LMIGSYASSAITFPG HHHHHHHCCCCCCCC | 16.45 | 26552605 | |
| 178 | Phosphorylation | MIGSYASSAITFPGI HHHHHHCCCCCCCCC | 18.60 | 26552605 | |
| 181 | Phosphorylation | SYASSAITFPGIKLI HHHCCCCCCCCCHHH | 24.40 | 26552605 | |
| 212 | N-linked_Glycosylation | LACLIFLNCTLNWPI HHHHHHHHCCCCCCH | 13.13 | UniProtKB CARBOHYD | |
| 229 | N-linked_Glycosylation | FPAPEEVNYTKKIKL CCCCCCCCCCCEEEE | 41.87 | UniProtKB CARBOHYD | |
| 235 | Ubiquitination | VNYTKKIKLSGLALD CCCCCEEEECCCCCC | 45.54 | - | |
| 237 | Phosphorylation | YTKKIKLSGLALDHK CCCEEEECCCCCCCE | 27.10 | 25072903 | |
| 244 | Ubiquitination | SGLALDHKVTGDLFY CCCCCCCEECCCCCC | 40.95 | - | |
| 246 | Phosphorylation | LALDHKVTGDLFYTH CCCCCEECCCCCCEE | 29.76 | 21945579 | |
| 251 (in isoform 2) | Phosphorylation | - | 11.84 | 27642862 | |
| 251 | Phosphorylation | KVTGDLFYTHVTTMG EECCCCCCEEECHHH | 11.84 | 21945579 | |
| 252 | Phosphorylation | VTGDLFYTHVTTMGQ ECCCCCCEEECHHHH | 11.53 | 21945579 | |
| 255 | Phosphorylation | DLFYTHVTTMGQRLS CCCCEEECHHHHHHH | 11.94 | 21945579 | |
| 256 | Phosphorylation | LFYTHVTTMGQRLSQ CCCEEECHHHHHHHH | 20.44 | 29978859 | |
| 262 (in isoform 2) | Phosphorylation | - | 31.65 | 27642862 | |
| 262 | Phosphorylation | TTMGQRLSQKAPSLE CHHHHHHHHCCCCCC | 31.65 | 28450419 | |
| 264 (in isoform 1) | Ubiquitination | - | 59.91 | 21906983 | |
| 264 (in isoform 2) | Ubiquitination | - | 59.91 | 21906983 | |
| 264 | Ubiquitination | MGQRLSQKAPSLEDG HHHHHHHCCCCCCCC | 59.91 | 2190698 | |
| 267 | Phosphorylation | RLSQKAPSLEDGSDA HHHHCCCCCCCCCCC | 49.61 | 9722952 | |
| 272 | Phosphorylation | APSLEDGSDAFMSPQ CCCCCCCCCCCCCHH | 37.78 | 28464451 | |
| 277 | Phosphorylation | DGSDAFMSPQDVRGT CCCCCCCCHHHCCCC | 16.98 | 27251275 | |
| 284 | Phosphorylation | SPQDVRGTSENLPER CHHHCCCCCCCCCCC | 23.46 | 27470641 | |
| 285 | Phosphorylation | PQDVRGTSENLPERS HHHCCCCCCCCCCCC | 27.58 | 25072903 | |
| 298 | Phosphorylation | RSVPLRKSLCSPTFL CCCCCCHHHCCHHHH | 28.33 | 26552605 | |
| 301 | Phosphorylation | PLRKSLCSPTFLWSL CCCHHHCCHHHHHHH | 32.06 | 26552605 | |
| 303 | Phosphorylation | RKSLCSPTFLWSLLT CHHHCCHHHHHHHHH | 18.31 | 26552605 | |
| 307 | Phosphorylation | CSPTFLWSLLTMGMT CCHHHHHHHHHCCHH | 18.69 | 26552605 | |
| 310 | Phosphorylation | TFLWSLLTMGMTQLR HHHHHHHHCCHHHHH | 19.57 | 26552605 | |
| 314 | Phosphorylation | SLLTMGMTQLRIIFY HHHHCCHHHHHHHHH | 20.79 | 26552605 | |
| 321 | Phosphorylation | TQLRIIFYMAAVNKM HHHHHHHHHHHHHHH | 3.87 | - | |
| 382 | Ubiquitination | YIMDWRIKDCVDAPT HHHCCCHHHHCCCCC | 36.18 | - | |
| 382 (in isoform 2) | Ubiquitination | - | 36.18 | - | |
| 404 | Ubiquitination | ARDGVATKSIRPRYC CCCCCCCCCCCCCCH | 33.86 | - | |
| 404 (in isoform 2) | Ubiquitination | - | 33.86 | - | |
| 426 | Phosphorylation | AISAFTLTNLLLVGF HHHHHHHHHHHHHHH | 22.29 | - | |
| 558 | Phosphorylation | VLSGSEVTA------ EECCCCCCC------ | 23.69 | 24670416 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of LAT3_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of LAT3_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of LAT3_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
Oops, there are no PPI records of LAT3_HUMAN !! | ||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...